Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Medtronic Neuromodulation
483
•Medtronic Neuromodulation•January 24, 2007

Medtronic Neuromodulation – FDA 483, Jan 24, 2007

Record Details

An FDA inspection of Medtronic Neurological, conducted from November 2006 to January 2007, revealed several critical quality system deficiencies. The company's risk analysis for SynchroMed pumps and intrathecal catheters was found incomplete, notably failing to identify inflammatory mass, granuloma, or fibrosis as potential hazards, contrary to their own procedures. Corrective and preventive action (CAPA) procedures were inadequately implemented; numerous product comment reports (PCRs) detailing serious adverse events, such as paralysis and subarachnoid hemorrhage, were not properly evaluated, ranked, or closed without adequate investigation or risk assessment. Furthermore, Medtronic failed to adhere to complaint handling protocols, neglecting to process relevant medical and scientific literature for potential Medical Device Reporting (MDR) evaluation. The inspection also highlighted a lack of supporting data for claims of reduced inflammatory mass incidence, with actual reported rates significantly higher than previously communicated. The firm had not fully identified all necessary actions to address ongoing quality issues, including previously mishandled adverse events. Crucially, many serious adverse events reported by healthcare professionals, patients, or family members were not submitted as MDRs within the required timeframe. Additionally, a significant customer communication in July 2003 regarding inflammatory masses, including revised labeling, was not reported to the FDA as a correction or removal. Medtronic committed to correcting these observations.

Company
Medtronic Neuromodulation
Inspection date
January 24, 2007
Product type
devices
Office
Minneapolis District Office
People
  • Timothy G. Philips
  • Susan Alpert (Senior Vice President)
  • Jocelyn Muggli (Consumer Safety Officer)
View Company Profile

ID · 4ed7e9e9-c2c3-4dd5-9bb9-d44ecb4018c4

Other documents for Medtronic Neuromodulation
  • 483 - 2023-05-05May 5, 2023
  • EIR - 2023-05-05May 5, 2023
  • 483 - 2022-11-03November 3, 2022
  • 483 - 2019-10-17October 17, 2019
  • 483 - 2017-06-30June 30, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Medtronic Neuromodulation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.